MoonLake Immunotherapeutics (MLTX) vs MannKind Corporation (MNKD)

MoonLake Immunotherapeutics and MannKind Corporation are both Biotechnology companies. MoonLake Immunotherapeutics and MannKind Corporation are of similar size ($1.1B and $1.0B). MoonLake Immunotherapeutics has the higher net margin (0.00% vs −11.1%) and the lower return on invested capital (0.00% vs 2.36%). Across the 13 metrics below, MannKind Corporation leads on 9 and MoonLake Immunotherapeutics on 4.

Valuation

Metric MLTX MNKD Biotechnology median
P/E n/m n/m 7.88
P/S n/m 2.62 11.47
P/B 2.08 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 42.70 0.74
EV/Sales n/m 3.41 10.73
Earnings yield (31.89%) (3.89%) (28.84%)
Free cash flow yield (25.31%) (1.76%) (23.03%)

Profitability

Metric MLTX MNKD Biotechnology median
Gross margin 0.00% 75.39% 65.16%
Operating margin 0.00% 2.34% 0.00%
Net margin 0.00% (11.08%) 0.00%
Free cash flow margin 0.00% (4.61%) 0.00%
Return on equity (67.08%) 71.36% (57.72%)
Return on assets (51.00%) (7.62%) (49.22%)
Return on invested capital 0.00% 2.36% 0.00%

Growth

Metric MLTX MNKD Biotechnology median
Revenue growth (TTM) — 30.46% 5.64%
EPS growth (last fiscal year) (86.77%) (80.00%) —
Revenue growth, 5-year CAGR — 39.89% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MLTX MNKD Biotechnology median
Debt to equity 0.23 (6.28) 0.00
Current ratio 12.56 1.72 4.73
Net debt to EBITDA 1.32 5.32 0.96

Dividend

Metric MLTX MNKD Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric MLTX MNKD Biotechnology median
Market cap 1.03b 1.06b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack